Evaluating the Growth Potential of the US Hydrocephalus Shunts Market

According to our new research study on “US Hydrocephalus Shunts Market Forecast to 2030 – Country Analysis – by Product, Type, Age Group, and End User,” the US hydrocephalus shunts market size is expected to reach US$ 146.24 million by 2030 from US$ 109.61 million in 2022. The market is estimated to grow at a CAGR of 3.7% from 2022 to 2030. The report highlights trends prevailing in the US hydrocephalus shunts market growth. The US hydrocephalus shunts market growth is attributed to advancements in hydrocephalus management devices and the surging prevalence of hydrocephalus.

Increasing Partnerships to Aid in Smart Functioning of Hydrocephalus Shunts to Boost US Hydrocephalus Shunts Market Growth During Forecast Period

US hydrocephalus shunts market companies are implementing strategies such as joint ventures and partnerships to extend their market shares. In June 2020, Rhaeos, Inc. received FDA Breakthrough Device designation for its FlowSense, a noninvasive thermal sensor. The sensor assesses hydrocephalus shunt flow within minutes. In 2020, Aesculap, Inc. partnered with Christoph Miethke GmbH & Co. KG (MIETHKE), and together they announced the launch of the M.blue hydrocephalus valve in the US. Its unique gravity technology is integrated with a fixed differential pressure unit in a valve, enabling a simple, position-dependent adjustment of the opening pressure during the patient’s most active time. Many market players are focused on developing “smart shunts” that could provide an understanding of flow or volume rates over time. Several industry partners are also developing devices that use thermodilution to estimate flow through a distal catheter to diagnose shunt malfunction. Thus, the increasing number of partnerships to aid in the intelligent functioning of hydrocephalus shunts would lead to new future trends in the US hydrocephalus shunts market.

Increasing funding to support hydrocephalus treatments is also likely to favor the growth of the US hydrocephalus shunts market. For instance, in August 2021, the National Institute of Neurological Disorders and Stroke (NINDS) granted US$ 14 million to researchers at the Johns Hopkins Cerebral Fluid Center, the Department of Neurosurgery, for hydrocephalus treatment studies. The Johns Hopkins Cerebral Fluid Center is conducting the research in partnership with the Adult Hydrocephalus Clinical Research Network (AHCRN). It is coordinated by the Hydrocephalus Association, a nonprofit organization that raises awareness and supports hydrocephalus research. Similarly, in September 2023, ?Carolyn Harris, associate professor of chemical engineering and materials science at Wayne State University, received a renewal of a research project (RO1) grant totaling $2,666,756?from the National Institutes of Health. The total amount for the entire RO1, from 2016-27, will accumulate to $5,345,009.

US Hydrocephalus Shunts Market: Segmental Overview

The “US Hydrocephalus Shunts Market” is segmented on the basis of product, type, age group, and end user. Based on the product, it is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment held the largest market share in 2022 and is projected to witness fastest growth during the forecast period. The US hydrocephalus shunts market, by type, is segmented into ventriculoperitoneal, ventriculoatrial, ventriculopleural, and lumboperitoneal. The ventriculoperitoneal segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030. The US hydrocephalus shunts market, by age group, is segmented into pediatric and adults. The pediatric segment held a largest market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022–2030. The US hydrocephalus shunts market, by end user, is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030.

US Hydrocephalus Shunts Market: Competitive Landscape and Key Developments

B. Braun SE, Sophysa SA, Integra LifeSciences Holdings Corp, KANEKA MEDIX CORP, Medtronic Plc, Natus Medical Inc, Anuncia Inc, and Desu Medical are among the leading companies operating in the US hydrocephalus shunts market. These players focus on expanding and diversifying their market presence and acquiring a novel customer base, thereby tapping prevailing business opportunities in the US hydrocephalus shunts market. Many market players are launching innovative with advanced features.

Contact Us: [email protected]